Nektar Therapeutics (NASDAQ:NKTR) shares fell to a low of $17.365 before closing at $17.75. Intraday shares traded counted 0.78 million, which was 12.96% higher than
Nektar Therapeutics (NASDAQ:NKTR) has a beta of 1.50. The stock’s Relative Strength Index (RSI) is 29.53, with weekly volatility at 4.19% and ATR at 0.70.
Nektar Therapeutics (NASDAQ:NKTR) has a beta of 1.51. The stock’s Relative Strength Index (RSI) is 42.52, with weekly volatility at 2.96% and ATR at 0.71.
Nektar Therapeutics (NASDAQ:NKTR) shares fell to a low of $17.42 before closing at $18.04. Intraday shares traded counted 0.56 million, which was 39.02% higher than
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
